Wien Klin Wochenschr 2006; 118: 327-35 MEDLINE e97. Raft D Gregg J Ghia J Harris L: Effects of intravenous tetrahydrocannabinol on experimental and surgical pain: psychological correlates of the analgesic response. Clin Pharmacol Ther 1977; 21: 26-33 MEDLINE e98. Cannabidiol 2012 buggy DJ Toogood L Maric S Sharpe P Lambert DG Rowbotham DJ: Lack of analgesic efficacy of oral delta-9-tetrahydrocannabinol in postoperative pain. Pain 2003; 106: 169-72 MEDLINE e99.
- Clin Pharmacol Ther 1977; 21: 26-33 MEDLINE e98
- The revision allows you to ask for a waiver so that within a particular clinical trial you have the ability to alter the dosing of the drug in the study” Saneto told CBS News
- A randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine
- If your referring neurologist has any questions please have them call the Program Manager at 205-975-8883
- Low dose treatment with the synthetic cannabinoid Nabilone significantly reduces spasticity-related pain : a double-blind placebo-controlled cross-over trial
. Ungerleider JT Sarna G Fairbanks LA Goodnight J Andrysiak T Jamison K: THC or compazine for the cancer chemotherapy patient – the UCLA study. Part II: patient drug preference. Am J Clin Oncol 1985; 8: 142-7. MEDLINE e34.
MEDLINE e55. Hutcheon AW Palmer JB Soukop M et al.: A randomised multicentre single blind comparison of a cannabinoid anti-emetic (levonantradol) with ychlorpromazine in patients receiving their first cytotoxic chemotherapy. Eur J Can Clin Oncol 1983; 19: 1087-90. MEDLINE e56. Stambaugh Jr JE McAdams J Vreeland F: Dose ranging evaluation of the antiemetic efficacy and toxicity of intramuscular levonantradol in cancer subjects with chemotherapy-induced emesis. Int J Clin Pharmacol Res best way to extract hash oil 1984; 24: 480-5. MEDLINE hemp seed oil when pregnant e57.
MEDLINE e67. Regelson W Butler JR Schulz J et al.: Delta-9-tetrahydrocannabinol as an effective antidepressant and appetite-stimulating agent in advanced cancer patients. In: Braude MC Szara S (eds.): Pharmacology of marihuana. Vol 2. New York: Raven Press 1976; 763-76. e68.
Killestein J Hoogervorst EL Reif M et al.: Safety tolerability and efficacy Cannabidiol 2012 of orally administered cannabinoids in MS. Neurology 2002; 58: 1404-7. MEDLINE e2. Zajicek J Fox P Sanders H et al.: Cannabinoids for treatment of spasticity and other hemp oil vs weed oil symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial. Lancet 2003; 362: 1517-26. MEDLINE e3.
I think more areas will legalize medical cannabis use. Hopefully this will prompt more people to educate themselves about Cannabidiol. Lambert DM: Cannabinoids in Nature and Medicine. Weinheim: Wiley-Vch. Verlag GmbH & Co.
Smoked cannabis for chronic neuropathic pain: a randomized controlled trial. CMAJ 2010; 182: 694-701 MEDLINE e84. Karst M Salim K Burstein S Conrad I Hoy L Schneider U: Analgesic effect of the synthetic cannabinoid CT-3 on indian hemp oil for cancer chronic neuropathic pain: a randomized controlled trial.